Top Section/Ad
Top Section/Ad
Most recent
LBBW's global head of corporates and DCM Patrick Seifert expects higher pre-funding in late 2026
Company has sold part of its business, leading ABS investor to covet proceeds
New government is seeking an IMF deal, which will likely require a debt rework
Fall of Amplifi Capital due to credit deterioration as opposed to fraud
More articles/Ad
More articles/Ad
More articles
-
The Russian IPO market has a strong pipeline of listings being prepared for execution over the rest of the year. However, getting deals done could grow much harder with the threat of fresh sanctions against the country from a new US president threatening to derail the market. -
The Senate Banking Committee approved the nomination of Gary Gensler as chair of the Securities and Exchange Commission and Rohit Chopra as director of the Consumer Financial Protection Bureau, allowing the two picks by US president Joe Biden to advance to the Senate floor. The restoration of consumer protection initiatives removed under the Trump administration is expected to follow a successful confirmation by Chopra.
-
Short sellers get a lot of stick, whether it is Elon Musk taunting them, an army of Redditors squeezing them or the corporations they target otherwise harassing, suing and investigating them. But they play a vital part in capital markets, as underlined by the Greensill affair — where the finance firm’s private status meant that for too long it could hide from the accountability that short sellers can help deliver.
-
Davy, the Irish brokerage firm, has shut its bond desk with immediate effect following a damning investigation by the Central Bank of Ireland which found a group of employees breached markets regulation for personal financial again over a period of two years.
-
The London listing review, out this week, has been hailed as a vital chance for the City to straighten its slipping crown as Europe’s top financial centre.
-
The US this week confirmed it would follow the EU and sanction certain Russian individuals in connection with the poisoning of prominent opposition leader and Kremlin critic Alexei Navalny. The announcements did not move markets, and are a far cry from the worst-case scenario some had feared.
